Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001171520-22-000185
Filing Date
2022-03-07
Accepted
2022-03-07 15:53:10
Documents
4

Document Format Files

Seq Description Document Type Size
1 eps10121.htm SC 13D/A 662937
2 JOINT FILING AND SOLICITATION AGREEMENT ex99-1.htm EX-99 18493
3 FORM OF NOMINEE INDEMNIFICATION AGREEMENT ex99-2.htm EX-99 10945
4 FORM OF POWER OF ATTORNEY ex99-3.htm EX-99 7270
  Complete submission text file 0001171520-22-000185.txt   700972
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 22717943
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 FLETCHER AVENUE SUITE 501 FORT LEE NJ 07024
Business Address
SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: SC 13D/A